1526 - Somatic tumour gene testing for the diagnosis of diffuse large B cell lymphoma, multiple myeloma and non-Hodgkin lymphoma subtypes

Page last updated: 28 February 2020

Application Detail



Description of Medical Service

The characterisation of: rearrangements in BCL2, BC16, MYC genes for detection of cases of 'double-hit' diffuse large B cell lymphoma, which require more intensive chemotherapy in view of the more aggressive nature of the lymphoma; copy number changes or mutations for the diagnosis and classification of neoplasms or the detection of minimal residual disease of patients with plasma cell myeloma; and histological diagnosis and classification for rare subtypes of non-hodgkin lymphoma.

Description of Medical Condition

Diffuse large B cell lymphoma; copy number abberations and / or mutations fo the diagnosis and classification of plasma cell myeloma; and rare sub-types of non-hodgkin lymphoma that respond poorly to conventional chemotherapy.

Reason for Application

New MBS item

Medical Service Type


Previous Application Number

Not Applicable

Associated Documentation

Application Form

Application Form (Word 202 KB)
Application Form (PDF 1032 KB)

Consultation Survey

Consultation Survey (Word 508 KB)
Consultation Survey (PDF 306 KB)

PICO Confirmation


Assessment Report


Public Summary Document

Public Summary Document (Word 83 KB)
Public Summary Document (PDF 369 KB)

Meetings for this Application


12-13 April 2018




1-2 August 2019